| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.nglfinechem.com | |
| Market Cap | 1,546.70 Cr. | |
| Enterprise Value(EV) | 1,557.00 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 62.07 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 40.34 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 42.15 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 407.33 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 6.15 | Calculated using Price: 2,503.55 |
| Dividend Yield | 0.07 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.62 Cr. | 6,178,024 Shares |
| FaceValue | 5 | |
| About NGL Fine-Chem Ltd. | ||
| NGL Fine-chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It caters to various global companies to custom manufacture high quality pharmaceuticals with reliability and flexibility. | ||
| 1 Day |
|
-4.38% |
| 1 Week |
|
-7.10% |
| 1 Month |
|
+17.92% |
| 3 Month |
|
+31.25% |
| 6 Month |
|
+38.36% |
| 1 Year |
|
+77.38% |
| 2 Year |
|
+10.99% |
| 5 Year |
|
+466.06% |
| 10 Year |
|
+10529.75% |
| 5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 21.85 | 8.72 | 44.76 | 27.9 | 9.63 | |
| Return on Capital Employed (%) | 25.25 | 11.93 | 53.53 | 33.91 | 11.96 | |
| Return on Assets (%) | 13.49 | 5.5 | 31.42 | 20.61 | 7.27 |
| Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 92 | 99 | 154 | 203 | 223 | 242 | |
| Non Curr. Liab. | 12 | 12 | 11 | 8 | 6 | 6 | |
| Curr. Liab. | 45 | 43 | 42 | 66 | 58 | 75 | |
| Minority Int. | |||||||
| Equity & Liab. | 149 | 154 | 207 | 277 | 287 | 323 | |
| Non Curr. Assets | 63 | 73 | 83 | 103 | 124 | 129 | |
| Curr. Assets | 86 | 81 | 125 | 173 | 163 | 194 | |
| Misc. Exp. not W/O | |||||||
| Total Assets | 149 | 154 | 207 | 277 | 287 | 323 |
| Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 153 | 152 | 258 | 318 | 278 | 313 | |
| Other Income | 4 | 3 | 8 | 11 | 6 | 12 | |
| Total Income | 157 | 155 | 266 | 328 | 284 | 325 | |
| Total Expenditure | -121 | -132 | -178 | -249 | -243 | -262 | |
| PBIDT | 36 | 23 | 88 | 79 | 40 | 63 | |
| Interest | -3 | -3 | -2 | -2 | -2 | -1 | |
| Depreciation | -6 | -8 | -8 | -10 | -11 | -11 | |
| Taxation | -7 | -4 | -21 | -17 | -7 | -12 | |
| Exceptional Items | |||||||
| PAT | 20 | 8 | 57 | 50 | 21 | 38 | |
| Minority Interest | |||||||
| Share Associate | |||||||
| Other Related Items | 0 | 0 | 0 | 0 | |||
| Consolidated Net Profit | 20 | 8 | 57 | 50 | 20 | 38 | |
| Adjusted EPS | 33 | 13 | 92 | 81 | 33 | 62 |
| Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 9 | 20 | 27 | 14 | 35 | |
| Cash Fr. Inv. | -10 | -20 | -25 | -14 | -27 | |
| Cash Fr. Finan. | -1 | -1 | -1 | -1 | ||
| Net Change | -1 | 0 | 2 | -1 | 7 | |
| Cash & Cash Eqvt | 1 | 0 | 2 | 1 | 8 |
|
Thu, 02 May 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Duplicate share certificate Ajitkumar Patel |
|||||||||||||||||||||
|
Mon, 29 Apr 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: PALLAVI PEDNEKAR Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: cs@nglfinechem.com Name of the Chief Financial Officer: RAJESH NARAYAN LAWANDE Designation: WHOLE TIME DIRECTOR AND CFO EmailId: rajesh@nglfinechem.com Date: 29/04/2024 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. |
|||||||||||||||||||||
|
Fri, 19 Apr 2024
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot Submission of Postal Ballot Result |
| Fri, 03 May 2024 |
Closing Below Previous Low
|
Close Within 52 Week High Zone
|
Making Higher Highs for 2 Days
|
High Increase in 1 Month
|
High Increase in 3 Months
|
